MURRYSVILLE, Pennsylvania—Philips Respironics has remediated 2.683 million patients affected by its sleep device recall as of the beginning of February—99% of those it could—the company announced.
As of Feb. 2, the company said, it had remediated all but 80,000 of the “actionable” registrations, which it defined as those that included all information necessary to complete the process. Remediated patients include:
